======= TMEM230 =======
== Gene Information ==
* **Official Symbol**: TMEM230
* **Official Name**: transmembrane protein 230
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29058|29058]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96A57|Q96A57]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TMEM230&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TMEM230|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/617019|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a multi-pass transmembrane protein that belongs to the TMEM134/TMEM230 protein family. The encoded protein localizes to secretory and recycling vesicle in the neuron and may be involved in synaptic vesicles trafficking and recycling. Mutations in this gene may be linked to familial Parkinson's disease. [provided by RefSeq, Mar 2017].
* **UniProt Summary**: Involved in trafficking and recycling of synaptic vesicles. {ECO:0000269|PubMed:27270108}.
|DUF872|
|synaptic vesicle transport|
|synaptic vesicle localization|
|autophagosome|
|recycling endosome|
|synaptic vesicle|
|late endosome|
|trans-Golgi network|
|establishment of vesicle localization|
|vesicle localization|
|early endosome|
|establishment of organelle localization|
|cell junction|
|organelle localization|
|endoplasmic reticulum|
|establishment of localization in cell|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-3.62|
|[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-2.44|
|[[:results:exp210|LB-100 2μM R05 exp210]]|-2.42|
|[[:results:exp72|LB-100 4.1μM R02 exp72]]|-2.4|
|[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-2.38|
|[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|-2.26|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-2.11|
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-2.07|
|[[:results:exp274|Citral 50μM R06 exp274]]|-1.97|
|[[:results:exp519|RS-1 10μM R08 exp519]]|-1.93|
|[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-1.89|
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.87|
|[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.81|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.78|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.77|
|[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.76|
|[[:results:exp372|Ibrutinib 1μM R07 exp372]]|-1.75|
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.74|
|[[:results:exp492|iCRT14 30μM R08 exp492]]|-1.7|
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.7|
|[[:results:exp264|Arsenate 40μM R06 exp264]]|1.72|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.73|
|[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|2.51|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.56|
^Gene^Correlation^
|[[:human genes:a:atp8b2|ATP8B2]]|0.484|
|[[:human genes:t:tmem30a|TMEM30A]]|0.477|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15794
* **Expression level (log2 read counts)**: 5.31
{{:chemogenomics:nalm6 dist.png?nolink |}}